These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9834051)

  • 1. How to correctly calculate the proportions of the heterozygotes and homozygotes in the extensive metabolizers of a certain drug-metabolizing enzyme in an ethnic or racial population?
    Xie HG
    Clin Pharmacol Ther; 1998 Nov; 64(5):575. PubMed ID: 9834051
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined CYP2C9, VKORC1 and CYP4F2 frequencies among Amerindians, Mozambicans and Brazilians.
    Vargens DD; Damasceno A; Petzl-Erler ML; Suarez-Kurtz G
    Pharmacogenomics; 2011 Jun; 12(6):769-72. PubMed ID: 21692610
    [No Abstract]   [Full Text] [Related]  

  • 3. Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations.
    Kaneko A; Bergqvist Y; Taleo G; Kobayakawa T; Ishizaki T; Björkman A
    Pharmacogenetics; 1999 Jun; 9(3):317-26. PubMed ID: 10471063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe.
    Masimirembwa C; Bertilsson L; Johansson I; Hasler JA; Ingelman-Sundberg M
    Clin Pharmacol Ther; 1995 Jun; 57(6):656-61. PubMed ID: 7781265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in the study of pharmacogenetics in China in 1996].
    Xie H; Zhou H
    Zhonghua Yi Xue Za Zhi; 1997 Jan; 77(1):77-8. PubMed ID: 9596985
    [No Abstract]   [Full Text] [Related]  

  • 6. Populations and genetic polymorphisms.
    Weber WW
    Mol Diagn; 1999 Dec; 4(4):299-307. PubMed ID: 10671640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype analysis of the CYP2C19 gene in the Japanese population.
    Tsuneoka Y; Fukushima K; Matsuo Y; Ichikawa Y; Watanabe Y
    Life Sci; 1996; 59(20):1711-5. PubMed ID: 8890945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of S-mephenytoin 4'-hydroxylation in African-Americans.
    Edeki TI; Goldstein JA; de Morais SM; Hajiloo L; Butler M; Chapdelaine P; Wilkinson GR
    Pharmacogenetics; 1996 Aug; 6(4):357-60. PubMed ID: 8873222
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic polymorphism of drug metabolizing enzymes].
    Yokoi T; Kamataki T
    Seikagaku; 1997 Oct; 69(10):1196-9. PubMed ID: 9431010
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population.
    Sviri S; Shpizen S; Leitersdorf E; Levy M; Caraco Y
    Clin Pharmacol Ther; 1999 Mar; 65(3):275-82. PubMed ID: 10096259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of proton pump inhibitors.
    Barone JA; Horn JR
    Manag Care; 2001 Oct; 10(10 Suppl):11-6. PubMed ID: 11729442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between CYP2A6 and CYP2C19 mutant alleles.
    Lam K; Chow L; Leung T; Wing YK; Chiu HF; Garcia-Barceló M
    Clin Pharmacol Ther; 1999 Dec; 66(6):647. PubMed ID: 10613622
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of CYP2C19 alleles *1, *2 and *3 by multiplex polymerase chain reaction.
    Griese EU; Läpple F; Eichelbaum M
    Pharmacogenetics; 1999 Jun; 9(3):389-91. PubMed ID: 10471071
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship between phenytoin pharmacokinetics and the CYP2C19 genotype in Japanese epileptic patients.
    Watanabe M; Iwahashi K; Kugoh T; Suwaki H
    Clin Neuropharmacol; 1998; 21(2):122-6. PubMed ID: 9579299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.
    Takahashi H; Kashima T; Nomizo Y; Muramoto N; Shimizu T; Nasu K; Kubota T; Kimura S; Echizen H
    Clin Pharmacol Ther; 1998 May; 63(5):519-28. PubMed ID: 9630825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interethnic differences of drug-metabolizing enzymes.
    Gaedigk A
    Int J Clin Pharmacol Ther; 2000 Feb; 38(2):61-8. PubMed ID: 10706192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.
    Xiao ZS; Goldstein JA; Xie HG; Blaisdell J; Wang W; Jiang CH; Yan FX; He N; Huang SL; Xu ZH; Zhou HH
    J Pharmacol Exp Ther; 1997 Apr; 281(1):604-9. PubMed ID: 9103550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human liver mephenytoin 4'-hydroxylase cytochrome P-450 proteins and genes.
    Brian WR; Ged C; Bellew TM; Srivastava PK; Bork RW; Umbenhauer DR; Lloyd RS; Guengerich FP
    Drug Metab Rev; 1989; 20(2-4):449-65. PubMed ID: 2680390
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethnic and geographical distributions of CYP2C19 alleles in the populations of Southeast Asia.
    Yusuf I; Djojosubroto MW; Ikawati R; Lum K; Kaneko A; Marzuki S
    Adv Exp Med Biol; 2003; 531():37-46. PubMed ID: 12916779
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjects.
    Qin XP; Xie HG; Wang W; He N; Huang SL; Xu ZH; Ou-Yang DS; Wang YJ; Zhou HH
    Clin Pharmacol Ther; 1999 Dec; 66(6):642-6. PubMed ID: 10613621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.